(Q44222617)

1 December 2017

Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study (English)

1 reference

1 December 2017

0 references

1

Julia M L Brotherton

1 reference

1 December 2017

Masha Fridman

2

1 reference

1 December 2017

Cathryn L May

3

1 reference

1 December 2017

Genevieve Chappell

4

1 reference

1 December 2017

A Marion Saville

5

1 reference

1 December 2017

Dorota M Gertig

6

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 June 2011

1 reference

1 December 2017

1 reference

1 December 2017

377

1 reference

1 December 2017

2085-2092

1 reference

1 December 2017

9783

1 reference

maintained by WikiProject

1 December 2017

1 reference

Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960551-5

7 January 2021

The current state of introduction of HPV vaccination into national immunisation schedules in Europe: Results of the VENICE 2008 survey

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960551-5

7 January 2021

Measuring human papillomavirus (HPV) vaccination coverage and the role of the National HPV Vaccination Program Register, Australia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960551-5

7 January 2021

The predicted impact of vaccination on human papillomavirus infections in Australia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960551-5

7 January 2021

Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960551-5

7 January 2021

Optimal strategy to identify incidence of diagnostic of diabetes using administrative data

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960551-5

7 January 2021

Improved methods for estimating incidence from linked hospital morbidity data

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960551-5

7 January 2021

Estimating regression models with unknown break-points

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960551-5

7 January 2021

Development and duration of human papillomavirus lesions, after initial infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960551-5

7 January 2021

Efficacy of Human Papillomavirus-16 Vaccine to Prevent Cervical Intraepithelial Neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960551-5

7 January 2021

Human papillomavirus types by age in cervical cancer precursors: predominance of human papillomavirus 16 in young women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960551-5

7 January 2021

Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960551-5

7 January 2021

Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960551-5

7 January 2021

Predicted impact of vaccination against human papillomavirus 16/18 on cancer incidence and cervical abnormalities in women aged 20-29 in the UK.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960551-5

7 January 2021

Promising strategies for cervical cancer screening in the post-human papillomavirus vaccination era.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960551-5

7 January 2021

10.1016/S0140-6736(11)60551-5

Identifiers

DOI

1 reference

1 December 2017

1 reference